Meeder Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8
| Closed | – | – | 1558 |
|
|
2022
Q3 | $0 | Sell |
8
-1
| -11% | – | ﹤0.01% | 2291 |
|
|
2022
Q2 | $1K | Sell |
9
-20
| -69% | -$2.22K | ﹤0.01% | 2039 |
|
|
2022
Q1 | $2K | Buy |
+29
| New | +$2K | ﹤0.01% | 2055 |
|
|
2021
Q4 | – | Sell |
-3
| Closed | -$1K | – | 1929 |
|
|
2021
Q3 | $1K | Sell |
3
-24
| -89% | -$8K | ﹤0.01% | 2346 |
|
|
2021
Q2 | $7K | Buy |
27
+23
| +575% | +$5.96K | ﹤0.01% | 1830 |
|
|
2021
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 2234 |
|
|
2020
Q4 | $1K | Sell |
4
-1
| -20% | -$250 | ﹤0.01% | 1699 |
|
|
2020
Q3 | $1K | Sell |
5
-8
| -62% | -$1.6K | ﹤0.01% | 2014 |
|
|
2020
Q2 | $5K | Sell |
13
-31
| -70% | -$11.9K | ﹤0.01% | 1529 |
|
|
2020
Q1 | $12K | Buy |
44
+24
| +120% | +$6.55K | ﹤0.01% | 1442 |
|
|
2019
Q4 | $7K | Buy |
20
+3
| +18% | +$1.05K | ﹤0.01% | 1686 |
|
|
2019
Q3 | $5K | Sell |
17
-1,455
| -99% | -$428K | ﹤0.01% | 1767 |
|
|
2019
Q2 | $786K | Buy |
1,472
+1,419
| +2,677% | +$758K | 0.05% | 299 |
|
|
2019
Q1 | $27K | Buy |
53
+32
| +152% | +$16.3K | ﹤0.01% | 1004 |
|
|
2018
Q4 | $10K | Sell |
21
-190
| -90% | -$90.5K | ﹤0.01% | 1253 |
|
|
2018
Q3 | $194K | Sell |
211
-217
| -51% | -$200K | 0.01% | 508 |
|
|
2018
Q2 | $313K | Buy |
428
+294
| +219% | +$215K | 0.03% | 436 |
|
|
2018
Q1 | $213K | Hold |
134
| – | – | 0.02% | 446 |
|
|
2017
Q4 | $121K | Buy |
+134
| New | +$121K | 0.01% | 540 |
|